| Heart Rate Variability and Autonomic Control | Lifetime | 28 | US 11 | 99.79 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 12 | US 7 | 99.65 |
| Cardiovascular Health and Disease Prevention | Lifetime | 29 | US 11 | 99.74 |
| Blood Pressure and Hypertension Studies | Lifetime | 48 | US 23 | 99.75 |
| Sodium Intake and Health | Lifetime | 21 | US 12 | 99.42 |
| Hemodynamic Monitoring and Therapy | Lifetime | 85 | US 32 | 99.28 |
| Hormonal Regulation and Hypertension | Lifetime | 153 | US 62 | 99.14 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 306 | US 138 | 99.10 |
| Obstructive Sleep Apnea Research | Lifetime | 136 | US 62 | 98.80 |
| Non-Invasive Vital Sign Monitoring | Lifetime | 143 | US 43 | 98.33 |
| Blood properties and coagulation | Lifetime | 152 | US 89 | 98.20 |
| Acute Ischemic Stroke Management | Lifetime | 470 | US 181 | 98.62 |
| Cardiovascular and Diving-Related Complications | Lifetime | 121 | US 67 | 98.00 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 241 | US 92 | 98.21 |
| Heart rate and cardiovascular health | Lifetime | 26 | US 7 | 98.07 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 758 | US 296 | 98.23 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 919 | US 370 | 97.75 |
| Heart Failure Treatment and Management | Lifetime | 569 | US 270 | 97.94 |
| Cardiovascular Health and Risk Factors | Lifetime | 325 | US 192 | 95.87 |
| Cardiac Health and Mental Health | Lifetime | 680 | US 331 | 95.88 |
| Peripheral Artery Disease Management | Lifetime | 887 | US 463 | 95.74 |
| Climate Change and Health Impacts | Lifetime | 900 | US 307 | 94.88 |
| Migraine and Headache Studies | Lifetime | 621 | US 196 | 93.87 |
| Disaster Response and Management | Lifetime | 868 | US 436 | 92.68 |
| Healthcare Systems and Public Health | Lifetime | 703 | US 39 | 91.40 |
| Hemophilia Treatment and Research | Lifetime | 529 | US 204 | 94.12 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 517 | US 156 | 91.69 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 2 | US 1 | 99.75 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 2 | US 1 | 99.86 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 6 | US 3 | 99.77 |
| Sodium Intake and Health | 2021-2025 | 1 | US 1 | 99.70 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 3 | US 1 | 99.22 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 12 | US 4 | 99.23 |
| Hormonal Regulation and Hypertension | 2021-2025 | 16 | US 9 | 99.13 |
| Heart rate and cardiovascular health | 2021-2025 | 3 | US 1 | 98.42 |
| Cardiac Health and Mental Health | 2021-2025 | 114 | US 40 | 95.64 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 94 | US 56 | 95.18 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 818 | US 210 | 94.62 |
| Cardiovascular and exercise physiology | 2021-2025 | 339 | US 62 | 93.34 |
| Heart Failure Treatment and Management | 2021-2025 | 606 | US 194 | 92.94 |
| Migraine and Headache Studies | 2021-2025 | 249 | US 57 | 91.64 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 184 | US 29 | 86.93 |
| Mobile Health and mHealth Applications | 2021-2025 | 710 | US 197 | 85.99 |
| Medication Adherence and Compliance | 2021-2025 | 314 | US 122 | 84.13 |
| Non-Invasive Vital Sign Monitoring | 2021-2025 | 682 | US 103 | 84.87 |
| Obstructive Sleep Apnea Research | 2021-2025 | 935 | US 235 | 83.79 |
| GDF15 and Related Biomarkers | 2021-2025 | 340 | US 92 | 66.21 |
